248 related articles for article (PubMed ID: 14517874)
1. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions.
van Hoogmoed CG; Busscher HJ; de Vos P
J Biomed Mater Res A; 2003 Oct; 67(1):172-8. PubMed ID: 14517874
[TBL] [Abstract][Full Text] [Related]
2. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?
de Vos P; de Haan BJ; Kamps JA; Faas MM; Kitano T
J Biomed Mater Res A; 2007 Mar; 80(4):813-9. PubMed ID: 17058213
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating.
King A; Strand B; Rokstad AM; Kulseng B; Andersson A; Skjåk-Braek G; Sandler S
J Biomed Mater Res A; 2003 Mar; 64(3):533-9. PubMed ID: 12579568
[TBL] [Abstract][Full Text] [Related]
4. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy.
Strand BL; Mørch YA; Espevik T; Skjåk-Braek G
Biotechnol Bioeng; 2003 May; 82(4):386-94. PubMed ID: 12632394
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells.
de Vos P; Hoogmoed CG; Busscher HJ
J Biomed Mater Res; 2002 May; 60(2):252-9. PubMed ID: 11857431
[TBL] [Abstract][Full Text] [Related]
6. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid.
de Haan BJ; Rossi A; Faas MM; Smelt MJ; Sonvico F; Colombo P; de Vos P
J Biomed Mater Res A; 2011 Sep; 98(3):394-403. PubMed ID: 21630432
[TBL] [Abstract][Full Text] [Related]
7. Microcapsules made by enzymatically tailored alginate.
Strand BL; Mørch YA; Syvertsen KR; Espevik T; Skjåk-Braek G
J Biomed Mater Res A; 2003 Mar; 64(3):540-50. PubMed ID: 12579569
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical model of alginate-poly-L-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS.
Tam SK; Dusseault J; Polizu S; Ménard M; Hallé JP; Yahia L
Biomaterials; 2005 Dec; 26(34):6950-61. PubMed ID: 15975648
[TBL] [Abstract][Full Text] [Related]
9. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules.
Clayton HA; London NJ; Colloby PS; Bell PR; James RF
J Microencapsul; 1991; 8(2):221-33. PubMed ID: 1765902
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules.
Bünger CM; Gerlach C; Freier T; Schmitz KP; Pilz M; Werner C; Jonas L; Schareck W; Hopt UT; de Vos P
J Biomed Mater Res A; 2003 Dec; 67(4):1219-27. PubMed ID: 14624508
[TBL] [Abstract][Full Text] [Related]
11. Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions.
Ma X; Vacek I; Sun A
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(1):43-69. PubMed ID: 8055097
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids.
Bünger CM; Tiefenbach B; Jahnke A; Gerlach C; Freier T; Schmitz KP; Hopt UT; Schareck W; Klar E; de Vos P
Biomaterials; 2005 May; 26(15):2353-60. PubMed ID: 15585238
[TBL] [Abstract][Full Text] [Related]
13. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition.
Ponce S; Orive G; Hernández R; Gascón AR; Pedraz JL; de Haan BJ; Faas MM; Mathieu HJ; de Vos P
Biomaterials; 2006 Oct; 27(28):4831-9. PubMed ID: 16766026
[TBL] [Abstract][Full Text] [Related]
14. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules.
De Vos P; De Haan B; Van Schilfgaarde R
Biomaterials; 1997 Feb; 18(3):273-8. PubMed ID: 9031730
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
[TBL] [Abstract][Full Text] [Related]
16. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period.
de Vos P; van Hoogmoed CG; de Haan BJ; Busscher HJ
J Biomed Mater Res; 2002 Dec; 62(3):430-7. PubMed ID: 12209929
[TBL] [Abstract][Full Text] [Related]
17. The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules.
de Vos P; Spasojevic M; de Haan BJ; Faas MM
Biomaterials; 2012 Aug; 33(22):5552-9. PubMed ID: 22560199
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy.
Orive G; Tam SK; Pedraz JL; Hallé JP
Biomaterials; 2006 Jul; 27(20):3691-700. PubMed ID: 16574222
[TBL] [Abstract][Full Text] [Related]
19. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation.
Quong D; Neufeld RJ; Skjåk-Braek G; Poncelet D
Biotechnol Bioeng; 1998 Feb; 57(4):438-46. PubMed ID: 10099220
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
